Triclosan-containing medical devices

Details Triclosan-containing medical devices Triclosan-containing medical devices

1998-06-30

2000-08-22

Bockelman, Mark

Surgery

Means for introducing or removing material from body for...

Treating material introduced into or removed from body...

424422, 623 1, 428 351, A61M 532

Patent

active

061065056

DESCRIPTION:

BRIEF SUMMARY
2. BACKGROUND OF THE INVENTION

The present invention relates to medical devices comprising synergistic combinations of triclosan and chlorhexidine.
Whenever a medical device comes in contact with a patient, a risk of infection is created. Thus, a contaminated examination glove, tongue depressor, or stethoscope could transmit infection. The risk of infection dramatically increases for invasive medical devices, such as intravenous catheters, arterial grafts, intrathecal or intracerebral shunts and prosthetic devices, which not only are, themselves, in intimate contact with body tissues and fluids, but also create a portal of entry for pathogens.
A number of methods for reducing the risk of infection have been developed which incorporate antiinfective agents into medical devices, none of which have been clinically proven to be completely satisfactory. Such devices desirably provide effective levels of antiinfective agent during the entire period that the device is being used. This sustained release may be problematic to achieve, in that a mechanism for dispersing antiinfective agent over a prolonged period of time may be required, and the incorporation of sufficient amounts of antiinfective agent may adversely affect the surface characteristics of the device. The difficulties encountered in providing effective antimicrobial protection increase with the development of drug-resistant pathogens.
One potential solution to these problems is the use of a synergistic combination of antiinfective agents that requires relatively low concentrations of individual antiinfective agents which may have differing patterns of bioavailability.
Two well-known antiinfective agents are chlorhexidine and triclosan. The following patents and patent application relate to the use of chlorhexidine and/or triclosan in medical devices.
U.S. Pat. No. 4,723,950 by Lee relates to a microbicidal tube which may be incorporated into the outlet tube of a urine drainage bag. The microbicidal tube is manufactured from polymeric materials capable of absorbing and releasing antimicrobial substances in a controllable sustained time release mechanism, activated upon contact with droplets of urine, thereby preventing the retrograde migration of infectious organisms into the drainage bag. The microbicidal tube may be produced by one of three processes: (1) a porous material, such as polypropylene, is impregnated with at least one microbicidal agent, and then coated with a hydrophilic polymer which swells upon contact with urine, causing the leaching out of the microbicidal agent; (2) a porous material, such as high density polyethylene, is impregnated with a hydrophilic polymer and at least one microbicidal agent; and (3) a polymer, such as silicone, is compounded and co-extruded with at least one microbicidal agent, and then coated with a hydrophilic polymer. A broad range of microbicidal agents are disclosed, including chlorhexidine and triclosan, and combinations thereof. The purpose of Lee's device is to allow the leaching out of microbicidal agents into urine contained in the drainage bag; similar leaching of microbicidal agents into the bloodstream of a patient may be undesirable.
U.S. Pat. No. 5,091,442 by Milner relates to tubular articles, such as condoms and catheters, which are rendered antimicrobially effective by the incorporation of a non-ionic sparingly soluble antimicrobial agent, such as triclosan. The tubular articles are made of materials which include natural rubber, polyvinyl chloride and polyurethane. Antimicrobial agent may be distributed throughout the article, or in a coating thereon. A condom prepared from natural rubber latex containing 1% by weight of triclosan, then dipped in an aqueous solution of chlorhexidine, is disclosed. U.S. Pat. Nos. 5,180,605 and 5,261,421, both by Milner, relate to similar technology applied to gloves.
U.S. Pat. Nos. 5,033,488 and 5,209,251, both by Curtis et al., relate to dental floss prepared from expanded polytetrafluoroethylene (PTFE) and coated with microcrystalline wax. Antimicrobial agen

REFERENCES:
patent: 4605564 (1986-08-01), Kulla et al.
patent: 4723950 (1988-02-01), Lee
patent: 4994047 (1991-02-01), Walker et al.
patent: 5019096 (1991-05-01), Fox, Jr. et al.
patent: 5033488 (1991-07-01), Curtis et al.
patent: 5091442 (1992-02-01), Milner
patent: 5102401 (1992-04-01), Lambert et al.
patent: 5165952 (1992-11-01), Soloman et al.
patent: 5180605 (1993-01-01), Milner
patent: 5200194 (1993-04-01), Edgren et al.
patent: 5209251 (1993-05-01), Curtis et al.
patent: 5261421 (1993-11-01), Milner
patent: 5335373 (1994-08-01), Dangman et al.
patent: 5357636 (1994-10-01), Dresdner et al.
The Merck Index, An Encyclopedia of Chemicals, Drugs, and Biologicals, Tenth Edition (Merck & Co., Inc. Rahway, NJ, 1983), p. 1092.

Affiliated with

Also associated with

Rating

Triclosan-containing medical devices does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Triclosan-containing medical devices, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triclosan-containing medical devices will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-575235